India's Drug Pricing Watchdog Price Hike
The National Pharmaceutical Pricing Authority (NPPA) has announced a significant price increase for certain essential drugs due to rising production costs.
Key Drugs Affected
- Carboplatin
- Previous Price: ₹60.49 per ml
- New Price: ₹90.74 per ml
- Increase: 50%
- Cisplatin
- Previous Price: ₹7.26 per ml
- New Price: ₹10.89 per ml
- Increase: 50%
Reasons for Price Increase
Producers of these drugs have been facing challenges due to a significant rise in the cost of raw materials like platinum, making production unviable.
Impact on Healthcare
- Hospitals have reported shortages of these critical chemotherapy agents, which are under price control.
Additional Drug Price Adjustments
- Anti-tetanus Immunoglobulin Vials
- Prices of 250IU and 500IU vials increased by 50%.
- Initiated by a review petition from the Serum Institute of India.
- Vaccines
- Price increases for BCG, Rubella, and measles vaccines.
Government Regulation
The NPPA invoked its extraordinary powers under Para 19 of the Drug Price Control Order, 2013, to approve these price hikes.